Wiley
Get the report: Scientific discovery & AI

Four sectors. One chain.

The first cross-sector view of AI and the science-to-patient journey

AI is rewriting every stage of the science-to-patient journey, but the system carrying that responsibility isn't keeping pace. This report is for the people ready to change that — for science, and for the patients depending on it.


Report preview: Five tensions the ecosystem hasn't resolved. 1 Speed vs. quality of innovation. Is the goal a faster timeline, or a better success rate? The system is investing without deciding which metrics matter most. 2 Data overload vs. information shortage. There's more data than ever but most of it is siloed, project-scoped, or discarded. Failed experiments become invisible and provenance is lost at every handoff. 3 Capability vs. uptake. Younger clinicians over-trusted fluent AI answers while senior ones distrust and ignore them, and pharma rebuilds from scratch. Nobody has designed the path through. Complete the form to access the full report.

Please complete the form to download the report.

The view no single sector could produce on its own

As a result of unique collaboration between industries that rarely come together, this report looks at the whole science-to-patient chain at once. It draws on perspectives from across pharmaceutical research and development, health systems, AI and technology, publishing, and clinical practice to ask where AI is genuinely creating value, where it's introducing new risks, and what's actually holding the system back.

Some of the organizations that shaped this report

Novo Nordisk
BMJ Group
Queen Mary Intellectual Property Research Institute, University of London
Salesforce
Wiley and IQVIA convened the vital collaboration needed to make this report possible. They sit at opposite ends of the same chain - one where knowledge is born, one where it lands. The complementary position is what makes the findings in this report credible across every sector it speaks to.